Histone acetyltransferase PCAF is required for hedgehog-Gli-dependent transcription and cancer cell proliferation

Cancer Research

Volumn 73, Issue 20, 2013, Pages 6323-6333

  Malatesta, Martina ^a,b   Steinhauer, Cornelia ^a,b   Mohammad, Faizaan ^a,b   Pandey, Deo P ^a,b   Squatrito, Massimo ^d   Helin, Kristian ^a,b,c  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c University of Copenhagen   (Denmark)

^d Structural Biology and Biocomputing Programme   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; HISTONE H3; PROTEIN PATCHED; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE SILENCING; GLI1 GENE; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; INTRACELLULAR SIGNALING; MEDULLOBLASTOMA; MOLECULAR PATHOLOGY; PCAF GENE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PTCH GENE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANIMALS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; GLIOBLASTOMA; HEDGEHOG PROTEINS; HUMANS; MEDULLOBLASTOMA; MICE; NIH 3T3 CELLS; P300-CBP TRANSCRIPTION FACTORS; PROMOTER REGIONS, GENETIC; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 84885991039     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-12-4660     Document Type: Article

References (50)

1. Ingham PW. Hedgehog signaling: a tale of two lipids. Science 2001; 294:1879-81.
2. Ruiz i Altaba A, Sanchez P, Dahmane N. Gli and hedgehog in cancer: tumours, embryos and stem cells. Nat Rev Cancer 2002; 2:361-72.
3. McMahon AP, Ingham PW, Tabin CJ Developmental roles and clinical significance of Hedgehog signaling. Curr Top Dev Biol 2003; 53:1-114.
4. Taipale J, Beachy PA The Hedgehog and Wnt signalling pathways in cancer. Nature 2001; 411:349-54.
5. Taipale J, Cooper MK, Maiti T, Beachy PA Patched acts catalytically to suppress the activity of Smoothened. Nature 2002; 418:892-7.
6. Sasaki H, Hui C, Nakafuku M., Kondoh H. A binding site for Gli proteins is essential for HNF-3beta floor plate enhancer activity in transgenics and can respond to Shh in vitro. Development 1997; 124: 1313-22.
7. Kinzler KW, Vogelstein B. The GLI gene encodes a nuclear protein which binds specific sequences in the human genome. Mol Cell Biol 1990; 10:634-42.
8. Freeman M. Feedback control of intercellular signalling in development. Nature 2000; 408:313-9.
9. Stein U, Eder C, Karsten U., Haensch W, Walther W, Schlag PM GLI gene expression in bone and soft tissue sarcomas of adult patients correlates with tumor grade. Cancer Res 1999; 59:1890-5.
10. Thayer SP, di Magliano MP, Heiser PW, Nielsen CM, Roberts DJ, Lauwers G.Y., et al Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 2003; 425:851-6.
11. Unden AB, Zaphiropoulos PG, Bruce K, Toftgard R., Stahle-Backdahl M. Human patched (PTCH) mRNA is overexpressed consistently in tumor cells of both familial and sporadic basal cell carcinoma. Cancer Res 1997; 57:2336-40.
12. Watkins DN, Berman DM, Burkholder S.G., Wang B., Beachy PA, Baylin SB Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 2003; 422:313-7.
13. Roberts WM, Douglass EC, Peiper S.C., Houghton PJ, Look AT Amplification of the gli gene in childhood sarcomas. Cancer Res 1989; 49: 5407-13.
14. Kinzler KW, Bigner SH, Bigner D.D., Trent JM, Law ML, O'Brien SJ, et al Identification of an amplified, highly expressed gene in a human glioma. Science 1987; 236:70-3.
15. Nilsson M, Unden AB, Krause D, Malmqwist U., Raza K, Zaphiropoulos PG, et al Induction of basal cell carcinomas and trichoepitheliomas in mice overexpressing GLI-1. Proc Natl Acad Sci U S A 2000; 97: 3438-43.
16. Clement V, Sanchez P, de Tribolet N, Radovanovic I, Ruiz i Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol 2007; 17: 165-72.
17. Grachtchouk M, Mo R, Yu S., Zhang X, Sasaki H, Hui C.C., et al Basal cell carcinomas in mice overexpressing Gli2 in skin. Nat Genet 2000; 24:216-7.
18. Varjosalo M, Bjorklund M, Cheng F., Syvanen H, Kivioja T, Kilpinen S., et al Application of active and kinase-deficient kinome collection for identification of kinases regulating hedgehog signaling. Cell 2008; 133:537-48.
19. Bazzoli E, Pulvirenti T, Oberstadt M.C., Perna F., Wee B, Schultz N, et al MEF promotes stemness in the pathogenesis of gliomas. Cell Stem Cell 2012; 11:836-44.
20. Schmitz SU, Albert M, Malatesta M., Morey L, Johansen JV, Bak M, et al Jarid1b targets genes regulating development and is involved in neural differentiation. EMBO J 2011; 30:4586-600.
21. Taipale J, Chen JK, Cooper M.K., Wang B., Mann RK, Milenkovic L, et al Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine. Nature 2000; 406:1005-9.
22. Konig R, Chiang CY, Tu B.P., Yan SF, DeJesus PD, Romero A, et al A probability-based approach for the analysis of large-scale RNAi screens. Nat Methods 2007; 4:847-9.
23. Pasini D, Cloos PA, Walfridsson J, Olsson L., Bukowski JP, Johansen JV, et al JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 2010; 464:306-10.
24. Bruggeman SW, Hulsman D, Tanger E., Buckle T, Blom M, Zevenhoven J., et al Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell 2007; 12:328-41.
25. Marmorstein R, Roth SY Histone acetyltransferases: function, structure, and catalysis. Curr Opin Genet Dev 2001; 11:155-61.
26. Pasini D, Malatesta M, Jung H.R., Walfridsson J., Willer A, Olsson L, et al Characterization of an antagonistic switch between histone H3 lysine 27 methylation and acetylation in the transcriptional regulation of Polycomb group target genes. Nucleic Acids Res 2010; 38: 4958-69.
27. Northcott PA, Korshunov A, Witt H., Hielscher T, Eberhart CG, Mack S, et al Medulloblastoma comprises four distinct molecular variants. J Clin Oncol 2011; 29:1408-14.
28. Dahmane N, Sanchez P, Gitton Y., Palma V, Sun T, Beyna M., et al The Sonic Hedgehog-Gli pathway regulates dorsal brain growth and tumorigenesis. Development 2001; 128:5201-12.
29. Lee J, Kotliarova S, Kotliarov Y., Li AG, Su Q, Donin NM, et al Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006; 9:391-403.
30. Stecca B, Ruiz i Altaba A. A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers. EMBO J 2009; 28:663-76.
31. Bar EE, Chaudhry A, Farah M.H., Eberhart CG Hedgehog signaling promotes medulloblastoma survival via Bc/II. Am J Pathol 2007; 170: 347-55.
32. Ghizzoni M, Boltjes A, Graaf C., Haisma HJ, Dekker FJ Improved inhibition of the histone acetyltransferase PCAF by an anacardic acid derivative. Bioorg Med Chem 2010; 18:5826-34.
33. Eliseeva ED, Valkov V, Jung M., Jung MO Characterization of novel inhibitors of histone acetyltransferases. Mol Cancer Ther 2007; 6: 2391-8.
34. Wang Z, Zang C, Rosenfeld J.A., Schones DE, Barski A, Cuddapah S, et al Combinatorial patterns of histone acetylations and methylations in the human genome. Nat Genet 2008; 40:897-903.
35. Grant PA, Eberharter A, John S., Cook RG, Turner BM, Workman JL Expanded lysine acetylation specificity of Gcn5 in native complexes. J Biol Chem 1999; 274:5895-900.
36. Schiltz RL, Mizzen CA, Vassilev A, Cook R.G., Allis CD, Nakatani Y. Overlapping but distinct patterns of histone acetylation by the human coactivators p300 and PCAF within nucleosomal substrates. J Biol Chem 1999; 274:1189-92.
37. Kuo MH, Brownell JE, Sobel R.E., Ranalli TA, Cook RG, Edmondson DG, et al Transcription-linked acetylation by Gcn5p of histones H3 and H4 at specific lysines. Nature 1996; 383:269-72.
38. Jin Q, Yu LR, Wang L, Zhang Z., Kasper LH, Lee JE, et al Distinct roles of GCN5/PCAF-mediated H3K9ac and CBP/p300-mediated H3K18/27ac in nuclear receptor transactivation. EMBO J 2011; 30: 249-62.
39. Bachoo RM, Maher EA, Ligon K.L., Sharpless NE, Chan SS, You MJ, et al Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002; 1: 269-77.
40. Berman DM, Karhadkar SS, Hallahan A.R., Pritchard JI, Eberhart CG, Watkins DN, et al Medulloblastoma growth inhibition by Hedgehog pathway blockade. Science 2002; 297:1559-61.
41. Chen JK, Taipale J, Cooper M.K., Beachy PA Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 2002; 16:2743-8.
42. Sekulic A, Migden MR, Oro A.E., Dirix L., Lewis KD, Hainsworth JD, et al Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med 2012; 366:2171-9.
43. Lauth M, Bergstrom A, Shimokawa T., Toftgard R. Inhibition of GLImediated transcription and tumor cell growth by small-molecule antagonists. Proc Natl Acad Sci U S A 2007; 104:8455-60.
44. Hyman JM, Firestone AJ, Heine V.M., Zhao Y., Ocasio CA, Han K, et al Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade. Proc Natl Acad Sci U S A 2009; 106: 14132-7.
45. Hosoya T, Arai MA, Koyano T, Kowithayakorn T., Ishibashi M. Naturally occurring small-molecule inhibitors of hedgehog/GLI-mediated transcription. Chembiochem 2008; 9:1082-92.
46. Horing E, Podlech O, Silkenstedt B., Rota IA, Adamopoulou E, Naumann U. The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells. Anticancer Res 2013; 33:1351-60.
47. New M, Olzscha H, La Thangue NB. HDAC inhibitor-based therapies: can we interpret the code? Mol Oncol 2012; 6:637-56.
48. Canettieri G, Di Marcotullio L, Greco A, Coni S., Antonucci L, Infante P, et al Histone deacetylase and Cullin3-REN(KCTD11) ubiquitin ligase interplay regulates Hedgehog signalling through Gli acetylation. Nat Cell Biol 2010; 12:132-42.
49. Balasubramanyam K, Altaf M, Varier R.A., Swaminathan V., Ravindran A, Sadhale PP, et al Polyisoprenylated benzophenone, garcinol, a natural histone acetyltransferase inhibitor, represses chromatin transcription and alters global gene expression. J Biol Chem 2004; 279: 33716-26.
50. Stimson L, Rowlands MG, Newbatt Y.M., Smith NF, Raynaud FI, Rogers P, et al Isothiazolones as inhibitors of PCAF and p300 histone acetyltransferase activity. Mol Cancer Ther 2005; 4:1521-32.